IRIS- DESyne X2 in the IRIS-DES Registry
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age19+
SponsorSeung-Jung Park
About this trial
This study evaluates effectiveness and safety of DESyne X2 in Routine Clinical Practice.
Eligibility criteria
Qualifiers
Age 19 and more
Intervention with DeSyne X2 drug-eluting coronary stent
Agreed with written informed consent form
Disqualifiers
Intervention with DeSyne X2 drug-eluting coronary stent and other drug eluting stent at the same time
Life expectancy of 1year and under
Cardiac shock
Trial design
Treatments tested in this trial
- DESyne X2
Treatment groups
1,000 Participants
are divided into 1 treatment groupSponsors and collaborators
Seung-Jung Park
Lead sponsor
Asan Medical Center
Sponsor institution
CardioVascular Research Foundation, Korea
Collaborator
Source ClinicalTrials.gov